Page results
-
This information has been written for parents and carers whose child is having radiotherapy treatment to the whole lungs. The page explains the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain and spine. This treatment may also be referred to as whole central nervous system (CNS) or cranio-spinal radiotherapy.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the abdomen and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the chest, or mediastinum.
-
This page provides information about the Modified Exercise Test.
-
CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. University College London Hospitals (UCLH) is proud to be one of Europe’s leading centres for this advanced care.
-
This page is about histiocytic disorders treated at the UCLH haematology department.
-
This page aims to provide information about the syndrome haemophagocytic lymphohistiocytosis (HLH).
-
The FES service is for people who have an upper motor neuron neurological disorder, difficulty walking due to dropped foot and are 16 or over
File results
-
FOI/2024/0620 - Women/ birthing people diverted to other NHS trusts in 2024
-
FOI/2024/0623 - Patient numbers sent to use MRI scanner at London Zoo from 2014-2024
-
FOI/2024/0628 - Service personnel/ armed force families access to speech and language therapy for children who stammer
-
FOI/2024/0633 - Adults, children diagnosed/ living with Glycogen storage disease type V (Mcardle's disease)
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0648 - Performance management Policy for July 2020 to November 2022
-
FOI/2024/0651 - Family history units/ familial cancer services
-
FOI/2024/0652 - Overseas visitors invoiced in 2023/24
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0663 - Diagnosis discharge codes and cases 2018-19 to 2022-23